Bristlecone Advisors, LLC Danaher Corp Transaction History

Bristlecone Advisors, LLC

  • $1.24 Billion
  • Q3 2024

A detailed history of Bristlecone Advisors, LLC transactions in Danaher Corp stock. As of the latest transaction made, Bristlecone Advisors, LLC holds 18,474 shares of DHR stock, worth $4.36 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
18,474
Previous 18,554 0.43%
Holding current value
$4.36 Million
Previous $4.64 Million 10.79%
% of portfolio
0.41%
Previous 0.4%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024
SELL
$239.25 - $280.76 $19,140 - $22,460
-80 Reduced 0.43%
18,474 $5.14 Million
Q2 2024

Jul 25, 2024
BUY
$235.51 - $267.98 $315,818 - $359,361
1,341 Added 7.79%
18,554 $4.64 Million
Q1 2024

Apr 22, 2024
BUY
$224.58 - $256.19 $413,227 - $471,389
1,840 Added 11.97%
17,213 $4.3 Million
Q4 2023

Jan 25, 2024
SELL
$185.1 - $233.13 $14,067 - $17,717
-76 Reduced 0.49%
15,373 $3.56 Million
Q3 2023

Oct 16, 2023
BUY
$233.08 - $265.59 $95,096 - $108,360
408 Added 2.71%
15,449 $3.83 Million
Q2 2023

Aug 03, 2023
SELL
$224.99 - $256.14 $150,968 - $171,869
-671 Reduced 4.27%
15,041 $3.61 Million
Q1 2023

May 11, 2023
SELL
$239.75 - $277.0 $266,362 - $307,747
-1,111 Reduced 6.6%
15,712 $3.96 Million
Q4 2022

Feb 14, 2023
SELL
$241.42 - $282.29 $53,836 - $62,950
-223 Reduced 1.31%
16,823 $4.47 Million
Q3 2022

Oct 27, 2022
BUY
$247.06 - $1507.4 $34,094 - $208,021
138 Added 0.82%
17,046 $4.4 Million
Q2 2022

Jul 25, 2022
BUY
$237.11 - $299.66 $471,848 - $596,323
1,990 Added 13.34%
16,908 $4.29 Million
Q1 2022

Apr 22, 2022
BUY
$257.27 - $315.76 $64,832 - $79,571
252 Added 1.72%
14,918 $4.38 Million
Q4 2021

Jan 19, 2022
SELL
$292.08 - $329.01 $442,209 - $498,121
-1,514 Reduced 9.36%
14,666 $4.83 Million
Q3 2021

Oct 19, 2021
SELL
$272.21 - $332.43 $63,152 - $77,123
-232 Reduced 1.41%
16,180 $4.93 Million
Q2 2021

Jul 21, 2021
SELL
$225.08 - $271.69 $5,627 - $6,792
-25 Reduced 0.15%
16,412 $4.4 Million
Q1 2021

Apr 30, 2021
SELL
$212.38 - $245.9 $55,218 - $63,934
-260 Reduced 1.56%
16,437 $3.7 Million
Q4 2020

Jan 25, 2021
BUY
$212.5 - $245.46 $42,500 - $49,092
200 Added 1.21%
16,697 $3.71 Million
Q3 2020

Oct 20, 2020
SELL
$177.16 - $215.33 $175,565 - $213,392
-991 Reduced 5.67%
16,497 $3.55 Million
Q2 2020

Jul 16, 2020
SELL
$128.7 - $176.83 $21,235 - $29,176
-165 Reduced 0.93%
17,488 $3.09 Million
Q1 2020

Apr 16, 2020
SELL
$121.39 - $169.05 $250,548 - $348,919
-2,064 Reduced 10.47%
17,653 $2.44 Million
Q4 2019

Jan 21, 2020
BUY
$133.47 - $153.48 $349,157 - $401,503
2,616 Added 15.3%
19,717 $3.03 Million
Q3 2019

Oct 28, 2019
SELL
$135.4 - $146.47 $308,576 - $333,805
-2,279 Reduced 11.76%
17,101 $2.47 Million
Q2 2019

Jul 19, 2019
BUY
$124.88 - $143.73 $319,817 - $368,092
2,561 Added 15.23%
19,380 $2.77 Million
Q1 2019

Apr 23, 2019
BUY
$97.62 - $132.29 $31,531 - $42,729
323 Added 1.96%
16,819 $2.22 Million
Q4 2018

Jan 15, 2019
SELL
$94.85 - $109.54 $85,365 - $98,586
-900 Reduced 5.17%
16,496 $1.7 Million
Q3 2018

Oct 22, 2018
BUY
$98.13 - $108.9 $567,682 - $629,986
5,785 Added 49.82%
17,396 $1.89 Million
Q2 2018

Jul 31, 2018
BUY
$96.1 - $103.24 $102,346 - $109,950
1,065 Added 10.1%
11,611 $1.15 Million
Q1 2018

Apr 24, 2018
SELL
$92.16 - $103.8 $167,270 - $188,397
-1,815 Reduced 14.68%
10,546 $1.03 Million
Q4 2017

Jan 30, 2018
SELL
$85.26 - $94.62 $2,984 - $3,311
-35 Reduced 0.28%
12,361 $1.15 Million
Q3 2017

Oct 20, 2017
BUY
$79.29 - $88.45 $982,878 - $1.1 Million
12,396
12,396 $1.06 Million

Others Institutions Holding DHR

# of Institutions
2,508
Shares Held
542M
Call Options Held
7.07M
Put Options Held
4.55M
View Full List

About DANAHER CORP

DHR Quotes by TradingView
  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $172B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Bristlecone Advisors, LLC Portfolio

Follow Bristlecone Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bristlecone Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bristlecone Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email